According to Zydus Lifesciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.07. At the end of 2024 the company had a P/S ratio of 5.16.
Year | P/S ratio | Change |
---|---|---|
2024 | 5.16 | 37.84% |
2023 | 3.74 | 43.48% |
2022 | 2.61 | -21.4% |
2021 | 3.32 | -4.79% |
2020 | 3.49 | 88.33% |
2019 | 1.85 | -35.1% |
2018 | 2.85 | -31.01% |
2017 | 4.14 | 4.1% |
2016 | 3.97 | 10.23% |
2015 | 3.60 | -6.92% |
2014 | 3.87 | 62.95% |
2013 | 2.38 | -21.79% |
2012 | 3.04 |